SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-015820
Filing Date
2020-04-08
Accepted
2020-04-08 08:31:19
Documents
5
Period of Report
2020-05-21
Effectiveness Date
2020-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A phat-def14a_20200521.htm DEF 14A 850270
2 GRAPHIC gcromgbz15mz000001.jpg GRAPHIC 9469
3 GRAPHIC gcromgbz15mz000004.jpg GRAPHIC 46575
4 GRAPHIC gcromgbz15mz000002.jpg GRAPHIC 9469
5 GRAPHIC gcromgbz15mz000003.jpg GRAPHIC 47078
  Complete submission text file 0001564590-20-015820.txt   1006968
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39094 | Film No.: 20781192
SIC: 2834 Pharmaceutical Preparations